Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.
Latest data shows the largest indicative borrow rate increases among liquid option names include: Nikola (NKLA) 54.11% +2.11, U.S. Natural Gas ...
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...
Wall Street was moving higher still shortly after the open, on the back of slightly better-than-expected readings for US ...
The price of the 2025 GMC Sierra 2500HD / 3500 HD starts at $48,295 and goes up to $94,795 depending on the trim and options. The crew cab with the standard bed remains our Sierra 2500HD ...
Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...
Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.
Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...
Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...
Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results